Extracellular vesicles (EVs) have attracted interest due to their ability to provide diagnostic
information from liquid biopsies. Cells constantly release vesicles divers in size, content and …

Breast cancer is the most common cancer among women worldwide. Although the five-, ten-
and fifteen-year survival rates are good for breast cancer patients diagnosed with early …

Breast cancer is one of the most frequent malignancies among women worldwide. Based on
clinical and molecular features of breast tumors, patients are treated with chemotherapy …

Continuous revision of the histologic and stage-wise classification of lung cancer by the
World Health Organization (WHO) provides the foundation for therapeutic advances by …

Colorectal cancer (CRC) is one of the most common human malignancies accounting for
approximately 10% of worldwide cancer incidence and mortality. While early-stage CRC is …

Cancer is one of the three leading causes of death worldwide. Even after successful therapy
and achieving remission, the risk of relapse often remains. In this context, dormant residual …

Cancer is considered as the leading cause of death and the major barrier of longevity
globally. The high mortality of cancer is due to the malignant spread. However, if the disease …

Over the past decade, substantial developments have been made in the detection of
circulating tumor DNA (ctDNA)—cell‐free DNA (cfDNA) fragments released into the …

Circulating tumor cells (CTCs) are important biomarkers of liquid biopsy. The number and
heterogeneity of CTCs play an important role in cancer diagnosis and personalized …

Liquid biopsy (LB) is a minimally invasive method which aims to detect circulating tumor-
derived components in body fluids. It provides an alternative to current cancer screening …